Daré Bioscience, Inc. (DARE)
0.8208
+0.02
(+2.41%)
USD |
NASDAQ |
Aug 25, 16:00
0.8208
0.00 (0.00%)
After-Hours: 19:29
Daré Bioscience Total Assets (Quarterly) : 22.37M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.37M |
| March 31, 2026 | 27.83M |
| December 31, 2025 | 32.47M |
| September 30, 2025 | 30.75M |
| June 30, 2025 | 12.98M |
| March 31, 2025 | 18.62M |
| September 30, 2024 | 18.06M |
| June 30, 2024 | 23.61M |
| March 31, 2024 | 13.01M |
| December 31, 2023 | 21.28M |
| September 30, 2023 | 25.05M |
| June 30, 2023 | 23.21M |
| March 31, 2023 | 30.37M |
| December 31, 2022 | 43.83M |
| September 30, 2022 | 50.38M |
| June 30, 2022 | 51.39M |
| March 31, 2022 | 49.19M |
| December 31, 2021 | 55.81M |
| September 30, 2021 | 48.81M |
| June 30, 2021 | 14.82M |
| March 31, 2021 | 10.52M |
| December 31, 2020 | 7.551M |
| September 30, 2020 | 7.662M |
| June 30, 2020 | 8.570M |
| March 31, 2020 | 10.21M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.443M |
| September 30, 2019 | 3.882M |
| June 30, 2019 | 7.261M |
| March 31, 2019 | 5.020M |
| December 31, 2018 | 7.827M |
| September 30, 2018 | 10.80M |
| June 30, 2018 | 13.48M |
| March 31, 2018 | 16.63M |
| December 31, 2017 | 14.26M |
| September 30, 2017 | 23.27M |
| June 30, 2017 | 8.151M |
| March 31, 2017 | 15.95M |
| December 31, 2016 | 37.69M |
| September 30, 2016 | 40.13M |
| June 30, 2016 | 49.89M |
| March 31, 2016 | 63.02M |
| December 31, 2015 | 78.22M |
| September 30, 2015 | 80.12M |
| June 30, 2015 | 88.10M |
| March 31, 2015 | 59.38M |
| December 31, 2014 | 53.39M |
| September 30, 2014 | 60.09M |
| June 30, 2014 | 65.74M |
| March 31, 2014 | 11.85M |
| December 31, 2013 | 159.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 1.095B |
| Elite Pharmaceuticals, Inc. | 139.67M |
| Eton Pharmaceuticals, Inc. | 115.81M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.93M |
| Shareholders Equity (Quarterly) | -0.5601M |
| Debt to Equity Ratio | -12.08 |
| Current Ratio | 0.986 |
| Net Debt Paydown Yield | 1.03% |